Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
P106007-1g | 1g | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $16.90 | |
P106007-5g | 5g | In stock | $53.90 | |
P106007-10g | 10g | In stock | $93.90 | |
P106007-25g | 25g | In stock | $156.90 | |
P106007-50g | 50g | In stock | $238.90 | |
P106007-100g | 100g | In stock | $380.90 |
α 1 Adrenoceptor agonist
Synonyms | Phenylephrine HCl | PHENYLEPHRINE HYDROCHLORIDE (EP MONOGRAPH) | Benzyl alcohol, m-hydroxy-alpha-((methylamino)methyl)-, hydrochloride, (-)- | PHENYLEPHRINE HYDROCHLORIDE [USP MONOGRAPH] | Phenylephrine hydrochloride [USP:JAN] | D-(-)-Phenylephrine hydroc |
---|---|
Specifications & Purity | ≥99% |
Biochemical and Physiological Mechanisms | α1-adrenoceptor agonist.α 1 Adrenoceptor agonist. pK i values are 4.87, 4.70 and 5.86 for adrenoceptor subtypes α 1B , α 1C and α 1A/D , respectively. Vasoconstrictor. Active in vivo , may cross the blood-brain barrier. |
Storage Temp | Store at 2-8°C,Argon charged |
Shipped In | Wet ice |
Action Type | AGONIST |
Mechanism of action | Adrenergic receptor alpha-1 agonist |
Note | Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details. |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | 3-[(1R)-1-hydroxy-2-(methylamino)ethyl]phenol;hydrochloride |
---|---|
INCHI | InChI=1S/C9H13NO2.ClH/c1-10-6-9(12)7-3-2-4-8(11)5-7;/h2-5,9-12H,6H2,1H3;1H/t9-;/m0./s1 |
InChi Key | OCYSGIYOVXAGKQ-FVGYRXGTSA-N |
Canonical SMILES | CNCC(C1=CC(=CC=C1)O)O.Cl |
Isomeric SMILES | CNC[C@@H](C1=CC(=CC=C1)O)O.Cl |
WGK Germany | 3 |
RTECS | DO7525000 |
PubChem CID | 5284443 |
Molecular Weight | 203.67 |
Beilstein | 4158948 |
Reaxy-Rn | 4158948 |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
E2406453 | Certificate of Analysis | Mar 26, 2024 | P106007 |
E2406454 | Certificate of Analysis | Mar 26, 2024 | P106007 |
D2402410 | Certificate of Analysis | Mar 14, 2024 | P106007 |
D2402411 | Certificate of Analysis | Mar 14, 2024 | P106007 |
D2402412 | Certificate of Analysis | Mar 14, 2024 | P106007 |
D2402413 | Certificate of Analysis | Mar 14, 2024 | P106007 |
J2218246 | Certificate of Analysis | Aug 03, 2022 | P106007 |
J2218250 | Certificate of Analysis | Aug 03, 2022 | P106007 |
J2218275 | Certificate of Analysis | Aug 03, 2022 | P106007 |
J2218285 | Certificate of Analysis | Aug 03, 2022 | P106007 |
J2218286 | Certificate of Analysis | Aug 03, 2022 | P106007 |
J2218287 | Certificate of Analysis | Aug 03, 2022 | P106007 |
L2318076 | Certificate of Analysis | Aug 27, 2021 | P106007 |
Sensitivity | Moisture sensitive. |
---|---|
Specific Rotation[α] | -45.5 ° (C=1, H2O) |
Melt Point(°C) | 143°C |
Pictogram(s) | GHS08, GHS07 |
---|---|
Signal | Warning |
Hazard Statements | H315:Causes skin irritation H319:Causes serious eye irritation H335:May cause respiratory irritation H302:Harmful if swallowed H317:May cause an allergic skin reaction H312:Harmful in contact with skin H361:Suspected of damaging fertility or the unborn child |
Precautionary Statements | P261:Avoid breathing dust/fume/gas/mist/vapors/spray. P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing. P280:Wear protective gloves/protective clothing/eye protection/face protection. P302+P352:IF ON SKIN: wash with plenty of water. P321:Specific treatment (see ... on this label). P405:Store locked up. P501:Dispose of contents/container to ... P264:Wash hands [and …] thoroughly after handling. P271:Use only outdoors or in a well-ventilated area. P270:Do not eat, drink or smoke when using this product. P304+P340:IF INHALED: Remove person to fresh air and keep comfortable for breathing. P403+P233:Store in a well-ventilated place. Keep container tightly closed. P272:Contaminated work clothing should not be allowed out of the workplace. P333+P313:IF SKIN irritation or rash occurs: Get medical advice/attention. P362+P364:Take off contaminated clothing and wash it before reuse. P330:Rinse mouth. P203:Obtain, read and follow all safety instructions before use. P264+P265:Wash hands [and …] thoroughly after handling. Do not touch eyes. P301+P317:IF SWALLOWED: Get medical help. P318:if exposed or concerned, get medical advice. P317:Get emergency medical help. P337+P317:If eye irritation persists: Get medical help. P332+P317:If skin irritation occurs: Get medical help. P319:Get medical help if you feel unwell. |
WGK Germany | 3 |
RTECS | DO7525000 |
Reaxy-Rn | 4158948 |
Merck Index | 7286 |
Starting at $37.90
Starting at $119.90
1. Tyurin-Kuzmin PA et al.. (2016) Activation of ß-adrenergic receptors is required for elevated a1A-adrenoreceptors expression and signaling in mesenchymal stromal cells.. Sci Rep, 6 (32835). [PMID:27596381] |
2. Tyurin-Kuzmin PA et al.. (2018) Noradrenaline Sensitivity Is Severely Impaired in Immortalized Adipose-Derived Mesenchymal Stem Cell Line.. Int J Mol Sci, 19 (12): [PMID:30469522] |
3. Lippiello P et al.. (2015) Noradrenergic modulation of the parallel fiber-Purkinje cell synapse in mouse cerebellum.. Neuropharmacology, 89 (33-42). [PMID:25218865] |
4. Jiang DS et al.. (2016) The potential role of lysosome-associated membrane protein 3 (LAMP3) on cardiac remodelling.. Am J Transl Res, 8 (37-48). [PMID:27069538] |